Vertex Pharmaceuticals (NQ:VRTX)
Price and Volume
Detailed Quote| Volume | 265,029 |
| Open | 509.50 |
| Bid (Size) | 502.00 (360) |
| Ask (Size) | 502.61 (80) |
| Prev. Close | 506.74 |
| Today's Range | 499.95 - 509.50 |
| 52wk Range | 392.50 - 560.25 |
| Shares Outstanding | 259,428,394 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
10.3% below 52-week high
502.31
392.5052W Low
560.2552W High
1 Week
5.2% below 1-week high
505.271W Low
529.891W High
Vertex Pharmaceuticals (VRTX) traded between $392.50 and $560.25 over the past 52 weeks and last traded at $502.31, 10.3% below its 52-week high. Over the past week it ranged between $505.27 and $529.89.
Past 12 Months
1W
-$23.89
1M
-$45.34
3M
-$25.73
6M
+$63.60
YTD
+$50.18
1Y
+$98.10
VRTX was +24.3% over the past year, +14.5% over six months, +11.1% year to date, -4.5% in the last week.
12 Months vs Market
VRTX
+24.3%
DIA
+9.9%
SPY
+15.1%
QQQ
+24.4%
IWM
+16.1%
Over the past 12 months VRTX returned +24.3% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.1%, QQQ (Nasdaq 100) +24.4% and IWM (Russell 2000) +16.1%.
Volume & Liquidity
0.22× 3-mo avg
Today 265,029
3-mo avg 1.2M
1W
922.9K
1M
1.0M
3M
1.2M
6M
1.3M
YTD
1.4M
1Y
1.4M
VRTX most recently traded 265,029 shares against a 3-month average daily volume of 1.2M.
More News
Read More
2 Healthcare Stocks to Target This Week and 1 We Avoid
September 28, 2026
2 Healthcare Stocks That Just Delivered Great News for Investors ↗
September 26, 2026
3 Reasons CRISPR Therapeutics Stock Is Still a Buy After a Rocky 2026 ↗
September 20, 2026
Is This Biotech Stock Too Cheap to Ignore After Its Latest Pullback? ↗
September 18, 2026
2 Reasons to Like VRTX (and 1 Not So Much)
September 18, 2026
My Top 5 Favorite Stocks for an Uncertain Market ↗
September 16, 2026
1 Unpopular Stock That Should Get More Attention and 2 We Brush Off
September 14, 2026
Vertex Pharmaceuticals Maps Growth Beyond CF at Cantor Conference ↗
September 12, 2026
Why CRISPR Therapeutics Stock Rocked the Market Last Month ↗
September 08, 2026
Where Will CRISPR Therapeutics Stock Be in 5 Years? ↗
September 08, 2026
Replacing Insulin Cells Works. Keeping The Cells Alive Is the Trick
September 08, 2026
3 Market-Beating Stocks for Long-Term Investors
September 08, 2026
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now? ↗
September 04, 2026
Frequently Asked Questions
Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 502.31
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 10/02/26 12:05 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 130.31B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 130B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.